Nationwide
studies have shown that BRSV is present in 38% to 76% of
beef and dairy herds. Like
other viruses that attack the respiratory tract, BRSV
reduces the resistance of the respiratory tract and makes
the animal susceptible to secondary lung infections. If
sickness caused by BRSV is not diagnosed early, secondary
lung infections may mask the true cause of the illness. BRSV
disease occurs in cattle of all ages, but unless the herd
has been completely isolated from the disease agent, most
adult animals show little if any signs of the disease. BRSV,
however, has been identified as an important disease agent
in both nursing and weaned calves.
Symptoms
At
the beginning of BRSV in calves, there is a high-pitched dry
cough, a clear nasal discharge, and frequently a clear
discharge from the eyes. The calves continue to eat, but
back away from the feed before filling. They may show signs
of depression when left alone, but when approached, they
immediately brighten up and move around normally. Producers
who have not dealt with the disease before can easily miss
calves in this stage of the outbreak. In these situations,
the first noticeable sign of disease may be a dead calf. As
soon as some calves are recognized as being sick, a
temperature check on a group of calves helps determine the
extent of the outbreak. If many of the calves are going to
break with the disease within a day or two, a large
percentage will have body temperatures greater than 104°F.
As
the disease progresses and feed and water consumption
decreases, the calves become increasingly gaunt. The area
around the eye may begin to swell due to fluid accumulation
under the skin, and body temperatures can rise to around
108°F. As this fluid accumulation worsens, the area under
the jaw and throat begins to swell. There is frothy saliva
around the mouth and breathing becomes very labored,
especially when the calf is exerted. Eventually the tongue
is extended and the neck is stretched as breathing becomes
more difficult. At this point, preventing death is unlikely.
The same late syndrome occurs in feedyard calves; however,
because of the high incidence of secondary
infections,
many calves may die before the advanced stages of the
disease are observed.
Clinical
signs in adult cattle vary considerably; adult cattle raised
in herds where the virus is present tend to become infected
as they mature and exhibit few if any clinical signs. In
contrast, adult cattle that have not been vaccinated nor
exposed to the virus are very susceptible to clinical
disease and can exhibit severe respiratory distress. These
very susceptible adults can be gasping for breath within an
hour or two of the first signs of respiratory problems.
Frequently, they collapse and die with little or no
struggle. The short time in which these animals die is
astonishing; the day before they looked healthy and
vigorous. For years we diagnosed these sudden deaths in
adults as "fog fever" or "acute pulmonary
emphysema," and they were thought to be caused by an
allergic reaction to certain plants. It may have been an
allergic reaction, but an allergic reaction associated with
the virus can not be ruled out. One theory is that an
initial exposure to the virus in some cattle caused them to
be sensitized to the virus; a subsequent exposure would then
result in a severe allergic reaction. As we say, it's only a
theory.
Transmission
BRSV-infected
cattle are considered the principal reservoirs of the
disease. Since the disease is manifested as a respiratory
disease, transmission from one animal to another is thought
to be via aerosol droplets from the nose and throat. Due to
the mode of transmission, the length of time for the disease
to progress through an exposed herd depends upon the
confinement status of the herd. In feedyards and dairies,
where cattle are in close confinement, the disease can
spread rapidly through the cattle in 3 to 10 days. However,
in pastured cattle it may take several weeks or months to
get through the entire herd. Once exposed, it requires 2-4
days for a susceptible animal to begin showing clinical
signs of the disease. In susceptible herds undergoing a BRSV
outbreak, you can expect 100% of the animals to become
infected with the virus, 20-50% to show clinical signs, and
less than 5% to die.
Treatment
As with
other viruses, antibiotics have no affect on the BRSV
infection. However, antibiotic treatment is indicated in
attempts to control the secondary bacterial infections. In
addition to antibiotics, treatment during an outbreak of the
late syndrome in calves (also feedlot calves) would include
withholding concentrate feeds or silage for 2-3 days and
feeding only enough hay to identify animals that are off
feed. Severely affected calves that are unable to drink will
need supportive treatments consisting of fluids and
electrolytes.
The decision to vaccinate
your herd against BRSV should be based upon the
susceptibility of the herd. If on testing (serological) the
herd is found to be negative to BRSV, you have a very
susceptible herd. A vaccination program would be required to
raise the resistance of the herd against BRSV. If, on the
other hand, a significant number of adults were found to be
test-positive, one could assume that the BRSV virus was
present in the herd. Chances are that in such herds the
heifers kept as replacements will become infected, possibly
undergo the mild form of BRSV, and become nonsusceptible to
BRSV disease as they age. However, calves shipped from those
herds may leave the herd before they become infected; thus
they are susceptible to BRSV disease. Herd replacements such
as purchased heifers, cows and bulls could be very
susceptible to BRSV. Adding them to an infected herd could
be a problem for them.
Vaccination of herds in
which BRSV is known to exist will slow down the spread of
the virus through the herd, allowing susceptible animals to
get a low exposure rather than a high exposure to the BRSV
virus. Unfortunately, maternal antibodies against BRSV
passed to the calf via colostrum from vaccinated or infected
cows will not protect the calf from BRSV infections. Whether
those antibodies will reduce the severity of disease if the
calf gets infected, or to what extent the antibodies
interfere with vaccination of calves under four months of
age has not been determined. Therefore, vaccination of cows
against BRSV would not only reduce transmission to
susceptible cows and slow down the spread of the virus
through the herd, it would also reduce the spread of the
disease to the calves. Vaccination of the cow herd provides
a barrier. Calves should be vaccinated prior to weaning.
Presently all BRSV
vaccines are nonreplicating and can be administered to both
pregnant and nonpregnant cattle, regardless of whether they
are modified live or killed virus vaccines. Vaccinating
animals properly is different than just injecting an animal
with a vaccine. Proper BRSV vaccination requires two doses
initially, followed by an annual booster of one dose. The
initial two doses should be administered at least 21 days
apart and started when the animal is over 4 months of age.
BRSV vaccine can be purchased alone or in several
combinations with other vaccines such as IBR, BVD, PI3, and
Lepto-5.
Parainfluenza-3
virus (PI-3)
The PI-3
virus is relatively common in cattle and is found worldwide.
Affected animals exhibit watery to yellow-colored discharges
from the eyes and nose, coughs, increased respiration rates
and fever. By itself, PI-3 is a relatively mild infection;
death loss to the disease is rare, maybe even nonexistent.
However, it generally works in concert with IBR, BVD, BRSV,
pasteurella pneumonia and Haemophilus somnus
infections, making the mixed infections more damaging and
dangerous. Because PI-3 can enhance the damage of the other
diseases, PI-3 vaccines are almost always found combined
with IBR, BVD and/or BRSV vaccines.
As with most diseases,
calves are the most susceptible to PI-3; therefore,
vaccination of cows to provide maternal antibodies to the
newborn is recommended. In addition, calves should be
properly vaccinated before weaning and/or shipment.
PI-3 vaccines are
available in replicating, nonreplicating, and intranasal
forms. All three forms are safe for use in any age cattle,
regardless of the pregnancy status.
Replicating
PI-3 vaccine.
Modified
Live Virus -
usually requires only one injection to provide protection.
Vaccinate calves when they are over 4 months of age.
Non-replicating
PI-3 vaccine.
Killed
Virus and Chemically
Altered Virus vaccines require two doses initially and
an annual booster to provide adequate protection. Vaccinate
calves when they are over 4 months of age.
Intranasal
PI-3 vaccine.
The
resistance stimulated by intranasal PI-3 vaccine is rapid
but short lived and generally will stimulate resistance in
calves of any age. This is the vaccine form of choice when a
PI-3 exposure is anticipated. A booster vaccination with a
replicating or nonreplicating form of PI-3 vaccine is
required to provide longer protection.
Adding PI-3 to a
vaccination program is cheap. In fact, it is easier to find
respiratory vaccines that contain PI-3 than it is to find
one that does not contain PI-3.